Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
History and Philosophy of the Life Sciences|June 29, 2021
Seeing the value of experiential knowledge through COVID-19Sarah Atkinson, Hannah Bradby, Mariacarla Gadebusch Bondio, et al.Public Health Research (Southampton, England)|May 31, 2023
Impact of a social prescribing intervention in North East England on adults with type 2 diabetes: the SPRING_NE multimethod studySuzanne Moffatt, John Wildman, Tessa M Pollard, et al.Applied Ergonomics|November 29, 2016
Blood sampling - Two sides to the storyLaura Pickup, Sarah Atkinson, Erik Hollnagel, et al.Journal of Child and Adolescent Psychopharmacology|October 25, 2022
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic)Sarah Atkinson, Mary Bachinsky, Yaron Raiter, et al.Forensic Science International|January 23, 2016
Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incenseKaren Blakey, Sue Boyd, Sarah Atkinson, et al.Journal of Child and Adolescent Psychopharmacology|April 8, 2022
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication StudyRobert L Findling, Sarah Atkinson, Mary Bachinsky, et al.CNS Spectrums|November 14, 2018
Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension TrialsSarah Atkinson, Louise Thurman, Sara Ramaker, et al.The International Journal of Neuropsychopharmacology|February 24, 2010
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled studyNizar El-Khalili, Mark Joyce, Sarah Atkinson, et al.Journal of Child and Adolescent Psychopharmacology|November 30, 2017
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive DisorderSarah Atkinson, Shannon Lubaczewski, Sara Ramaker, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 29, 2015
Participatory design of a preliminary safety checklist for general practicePaul Bowie, Julie Ferguson, Marion MacLeod, et al.Pageof 11